DK170801B1 - Terapeutisk aktivt, substitueret benzimidazolderivat og fysiologisk acceptable salte og optiske enantiomerer heraf samt fremgangsmåde til fremstilling af samme, farmaceutisk præparat indeholdende benzimidazolderivatet, anvendelse af derivatet til fremstilling af et lægemiddel til hæmning af mavesyresekretionen hos pattedyr og til behandling af inflammatoriske mavetarmkanallidelser hos pattedyr sam - Google Patents

Terapeutisk aktivt, substitueret benzimidazolderivat og fysiologisk acceptable salte og optiske enantiomerer heraf samt fremgangsmåde til fremstilling af samme, farmaceutisk præparat indeholdende benzimidazolderivatet, anvendelse af derivatet til fremstilling af et lægemiddel til hæmning af mavesyresekretionen hos pattedyr og til behandling af inflammatoriske mavetarmkanallidelser hos pattedyr sam Download PDF

Info

Publication number
DK170801B1
DK170801B1 DK122391A DK122391A DK170801B1 DK 170801 B1 DK170801 B1 DK 170801B1 DK 122391 A DK122391 A DK 122391A DK 122391 A DK122391 A DK 122391A DK 170801 B1 DK170801 B1 DK 170801B1
Authority
DK
Denmark
Prior art keywords
derivative
compound
mammals
preparing
benzimidazole
Prior art date
Application number
DK122391A
Other languages
Danish (da)
English (en)
Other versions
DK122391A (da
DK122391D0 (da
Inventor
Arne Elof Braendstroem
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Carl Ingemar Starke
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of DK122391D0 publication Critical patent/DK122391D0/da
Publication of DK122391A publication Critical patent/DK122391A/da
Application granted granted Critical
Publication of DK170801B1 publication Critical patent/DK170801B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
DK122391A 1988-12-22 1991-06-21 Terapeutisk aktivt, substitueret benzimidazolderivat og fysiologisk acceptable salte og optiske enantiomerer heraf samt fremgangsmåde til fremstilling af samme, farmaceutisk præparat indeholdende benzimidazolderivatet, anvendelse af derivatet til fremstilling af et lægemiddel til hæmning af mavesyresekretionen hos pattedyr og til behandling af inflammatoriske mavetarmkanallidelser hos pattedyr sam DK170801B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8804628 1988-12-22
SE19888804628A SE8804628D0 (sv) 1988-12-22 1988-12-22 New compounds
SE8900741 1989-03-13
PCT/SE1989/000741 WO1990006926A1 (en) 1988-12-22 1989-12-20 Therapeutically active substituted benzimidazole and process for its preparation

Publications (3)

Publication Number Publication Date
DK122391D0 DK122391D0 (da) 1991-06-21
DK122391A DK122391A (da) 1991-06-24
DK170801B1 true DK170801B1 (da) 1996-01-22

Family

ID=20374309

Family Applications (1)

Application Number Title Priority Date Filing Date
DK122391A DK170801B1 (da) 1988-12-22 1991-06-21 Terapeutisk aktivt, substitueret benzimidazolderivat og fysiologisk acceptable salte og optiske enantiomerer heraf samt fremgangsmåde til fremstilling af samme, farmaceutisk præparat indeholdende benzimidazolderivatet, anvendelse af derivatet til fremstilling af et lægemiddel til hæmning af mavesyresekretionen hos pattedyr og til behandling af inflammatoriske mavetarmkanallidelser hos pattedyr sam

Country Status (26)

Country Link
US (1) US5019584A (de)
EP (1) EP0451188B1 (de)
JP (1) JP2793907B2 (de)
CN (1) CN1028232C (de)
AT (1) ATE110379T1 (de)
AU (1) AU636866B2 (de)
CA (1) CA2005987C (de)
DD (1) DD296077A5 (de)
DE (1) DE68917738T2 (de)
DK (1) DK170801B1 (de)
FI (1) FI913036A0 (de)
GR (1) GR1000318B (de)
HU (1) HUT57203A (de)
IE (1) IE64850B1 (de)
IL (1) IL92797A (de)
LT (1) LT3981B (de)
LV (1) LV10268B (de)
NO (1) NO178338C (de)
PH (1) PH27257A (de)
PT (1) PT92647B (de)
RO (1) RO110496B1 (de)
RU (1) RU2070199C1 (de)
SE (1) SE8804628D0 (de)
WO (1) WO1990006926A1 (de)
YU (1) YU242589A (de)
ZA (1) ZA899796B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL166209B1 (pl) * 1990-06-20 1995-04-28 Astra Ab Sposób wytwarzania nowych pochodnych benzimidazolu PL
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
US6016044A (en) * 1995-09-11 2000-01-18 Alaris Medical Systems, Inc. Open-loop step motor control system
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
US20050234103A1 (en) * 2002-03-26 2005-10-20 Reddy Manne S Crystalline forms of rabeprazole sodium
CA2517005A1 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
WO2005007115A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
AR045061A1 (es) * 2003-07-18 2005-10-12 Santarus Inc Formulacion farmaceutica y metodo para tratar trastornos gastrointestinales causados por acido
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (de) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4331671A (en) * 1981-01-09 1982-05-25 Sterling Drug Inc. 5-(Pyridinyl)-1H-benzimidazoles and 1-hydroxy-6-(pyridinyl)-1H-benzimidazoles and their cardiotonic use
IL71664A (en) 1983-05-03 1987-11-30 Byk Gulden Lomberg Chem Fab Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150979A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
SE8500996D0 (sv) * 1985-03-01 1985-03-01 Haessle Ab Method of treatment
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
GB8610607D0 (en) * 1986-04-30 1986-06-04 Smith Kline French Lab Chemical compounds
FR2593178B1 (fr) * 1986-01-20 1988-04-29 Esteve Labor Dr Derives de 2-benzimidazolylalkylthio (ou sulfinyle ou sulfonyle) leur preparation et leur application en tant que medicaments.
WO1989003830A1 (en) * 1987-10-30 1989-05-05 Aktiebolaget Hässle 2-pyridinylmethyl (sulfinyl or thio)benzimidazoles for treatment of diseases related to bone loss

Also Published As

Publication number Publication date
PT92647A (pt) 1990-06-29
IE64850B1 (en) 1995-09-06
CN1028232C (zh) 1995-04-19
NO178338C (no) 1996-03-06
PT92647B (pt) 1995-09-12
EP0451188A1 (de) 1991-10-16
SE8804628D0 (sv) 1988-12-22
LTIP1722A (en) 1995-07-25
ZA899796B (en) 1990-08-29
DK122391A (da) 1991-06-24
GR1000318B (el) 1992-06-25
IL92797A (en) 1994-12-29
RU2070199C1 (ru) 1996-12-10
DD296077A5 (de) 1991-11-21
JP2793907B2 (ja) 1998-09-03
AU636866B2 (en) 1993-05-13
LT3981B (en) 1996-06-25
NO912416D0 (no) 1991-06-20
US5019584A (en) 1991-05-28
HUT57203A (en) 1991-11-28
LV10268A (lv) 1994-10-20
CN1043714A (zh) 1990-07-11
YU242589A (en) 1991-04-30
HU901085D0 (en) 1991-09-30
IL92797A0 (en) 1990-09-17
PH27257A (en) 1993-05-04
IE894049L (en) 1990-06-22
EP0451188B1 (de) 1994-08-24
GR890100834A (en) 1991-03-15
CA2005987A1 (en) 1990-06-22
ATE110379T1 (de) 1994-09-15
RO110496B1 (ro) 1996-01-30
WO1990006926A1 (en) 1990-06-28
DE68917738T2 (de) 1994-12-22
AU4817690A (en) 1990-07-10
NO912416L (no) 1991-07-31
LV10268B (en) 1995-02-20
FI913036A0 (fi) 1991-06-20
CA2005987C (en) 1999-04-13
NO178338B (no) 1995-11-27
DE68917738D1 (de) 1994-09-29
DK122391D0 (da) 1991-06-21
JPH04502462A (ja) 1992-05-07

Similar Documents

Publication Publication Date Title
DK170801B1 (da) Terapeutisk aktivt, substitueret benzimidazolderivat og fysiologisk acceptable salte og optiske enantiomerer heraf samt fremgangsmåde til fremstilling af samme, farmaceutisk præparat indeholdende benzimidazolderivatet, anvendelse af derivatet til fremstilling af et lægemiddel til hæmning af mavesyresekretionen hos pattedyr og til behandling af inflammatoriske mavetarmkanallidelser hos pattedyr sam
US5008278A (en) Therapeutically active compound and a process for its preparation
US4965269A (en) Therapeutically active chloro substituted benzimidazoles
NZ207348A (en) Omeprazole-(5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl)-sulfinyl)-1h-benzimidazole)
CA2005980C (en) Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
NO178337B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktiv 5-fluor-2[[(4-cyklopropyl-(metoksy-2-pyridinyl)metylÅsulfinylÅ-1H-benzimidazol og mellomprodukter

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed